glp-1 receptor agonist atrial fibrillation risk Glucagon-Like Peptide-1 Protects Against and Atrial Remodeling in Type 2 Diabetic Mice The Emerging Role of Glucagon-like
Description
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: A multicentre, randomised, dose-response, phase 2 study
Schoretsanitis G, Weiler S, Barbui C, Raschi E, Gastaldon C
This is important because while a large number of immune cells in the gut are activated by GLP-1 very few immune cells containing GLP-1 receptors are present in other organs
Korol SV, Jin Z, Babateen O, Birnir B
Healthcare professionals can follow updates through organizations such as the American Diabetes Association and ongoing FDA communications regarding biosimilar development pathways
